Shahar Nisemblat

Title: Innovator Spotlight: Shahar Nisemblat in Kfar Saba, Israel

Introduction: Shahar Nisemblat is a prominent inventor based in Kfar Saba, Israel. He has made significant contributions in the field of immunology, most notably through his patent on immunoglobulin compositions.

Latest Patents: Shahar holds a patent titled "Immunoglobulin compositions and process for obtaining the same." This invention addresses the needs in immunotherapy by providing human plasma-derived immunoglobulin compositions that comprise low levels of thrombogenic agents and IgG aggregates. Furthermore, it offers methods for effectively removing active coagulation factors and IgG aggregates from a plasma-derived immunoglobulin composition.

Career Highlights: Shahar Nisemblat is currently affiliated with Kamada Ltd., a company dedicated to developing innovative biopharmaceuticals. His work involves advanced research in immunoglobulin therapies, showcasing his commitment to improving patient outcomes through innovative solutions.

Collaborations: Throughout his career, Shahar has collaborated with fellow innovator Yuval Sagiv. Together, they have contributed their expertise to enhance the potential of immunoglobulin therapies, pushing the boundaries of research and development in the biopharmaceutical industry.

Conclusion: Shahar Nisemblat represents the spirit of innovation in the field of immunology. His dedication to developing safer and more effective immunoglobulin compositions is paving the way for advancements in the treatment of various health conditions. Through his work at Kamada Ltd. and collaboration with peers, he continues to inspire future innovations in the medical field.